BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2018
View Archived Issues
The locus of alcohol's reward
Read More
GBM cells spread their message beyond death
Read More
FDA clears of IND application for OC-01 as treatment of dry eye disease
Read More
Kangpu initiates phase I study of KPG-121 for metastatic CRPC
Read More
Inovio reports phase I results for INO-4700 in MERS
Read More
Erimos Pharmaceuticals initiates phase I study of oral terameprocol
Read More
Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab
Read More
Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals
Read More
Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas
Read More
Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement
Read More
Melinta Therapeutics describes leads from the pyrrolocytosine class of antibiotics
Read More
Kymab to test KY-1044 in combination with atezolizumab in clinical trials
Read More
Researchers present preclinical data for [11C]NOP-46
Read More
European Commission approves Xeljanz for active psoriatic arthritis
Read More
Arsanis discontinues phase II study of ASN-100
Read More
Ziopharm initiates phase I trial of Ad-RTS-hIL-12 plus veledimex with nivolumab in recurrent GBM
Read More
INDIGO-1 study of gemcabene in severe hypertriglyceridemia meets primary endpoint
Read More
Trevena completes first-in-human study of TRV-250 for treatment of acute migraine
Read More
ProQR initiates phase I/II WINGS trial of QR-313
Read More
Phase III MEDALIST study of luspatercept meets primary and key secondary endpoints
Read More
EMA committee recommends approval of Cablivi for aTTP
Read More
New MAP4K1 inhibitors identified at Ariad Pharmaceuticals
Read More
FUJIFILM, Nagoya City University patent flycosylated chlorin e6 derivatives
Read More
Aclaris reports promising interim data from phase II trial of ATI-501 in severe alopecia areata
Read More
Preliminary in vivo pharmacokinetics for [125I]p93 reported
Read More
Novartis to spin off Alcon eye care devices business
Read More
Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661
Read More
G1T38 demonstrates safety and early evidence of antitumor activity in breast cancer
Read More
First-in-human results presented from VANCE study of ChAdOx1-MVA 5T4 vaccine
Read More
Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis
Read More